COVID-associated mucormycosis: A case series

Coronavirus disease 2019 (COVID-19) infections may be associated with a wide range of bacterial and fungal coinfections. Mucormycosis is more often seen in immunocompromised individuals, and complications of orbital and cerebral involvement are likely in diabetic ketoacidosis and with concomitant use of steroids. The most common risk factor associated with mucormycosis is diabetes mellitus in India. Early identification of high-morbidity conditions is crucial for optimal treatment and improved outcomes. A total of 20 patients with post-COVID mucormycosis were studied. Uncontrolled diabetes and excessive usage of steroids are two of the main factors aggravating the illness, and both of these must be properly checked. Early diagnosis and prompt management are required for a good prognosis and to achieve a less fulminant disease course in cases of postcoronavirus mucormycosis.